Indeed, Ki67 positive cells were much more abundant in wild-type control tumors compared to that of MCF7KD-SERTAD1 (Figure 5E,F), suggesting the promoting role of SERTAD1 in breast cancer cell proliferation. Here, MKI67 is linked to breast carcinoma.